Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples